Dr. H Syafruddin Arl, Sppd-Kgeh Mars
Dr. H Syafruddin Arl, Sppd-Kgeh Mars
Dr. H Syafruddin Arl, Sppd-Kgeh Mars
PENDARAHAN
SCBA
PENDARAHAN
GASTROINTESTINAL
PENDARAHAN
SCBB
PENDARAHAN SCBA
BATASAN
SCBA = Saluran Cerna Bagian Atas.
Pendarahan SCBA
Jejunum proksimal
Duodenum
Gaster
Esofagus
PENDARAHAN SCBA
PATOFISIOLOGI
PATOLOGI ANATOMI
1. HEMATEMESIS
2. MELENA
3. ANEMIA - Upper COGI blood loss
PSCBA VARISEAL PSCBA NON-VARISEAL
PVE
PVF
ETIOLOGI
SH
Hipertensi Portal
PHG
DASAR
PATOLOGI
ANATOMI :
Mucosal
DASAR
damages
ETIOLOGI :
Deeping
Gangguan
submucosal
Keseimbangan damages
Faktor Agresif /
DASAR
PATOFISIOLOG
I:
pH < 4
Aktivitas
Pepsin
meningkat
dlm mencerna
protein
(proteolityc
enzymes)
Irritabilitas
faktor
pembekuan
darah
Disagregasi
Syncope
Presyncope
Dyspepsia
Epigastric pain
Diffuse abdominal pain
Wight loss
Jaundice
KEKERAPAN
14%
43%
18%
41%
10%
12%
5%
2. Tanda Obyektif
- Haematemesis (coffee
ground emesis)
- Melaena
- Haematochezia (red or
maroon stool)
40 50%
70 80%
15 20%
www.patient.co.uk/doctor/Upper-Gastrointestinal-Bleeding.htm
Copyright 2011
pH
100
80
60
40
20
0
1
pH asam lambung
0
pH=6,0
Disagregasi=77%
20
40
Buffer
60
pH=6,4
Disagregasi=16%
80
pH=7,3
Disagregasi=0%
100
0
2
3
Waktu (menit)
Penelitian Green et al :
- membuktikan bahwa kondisi asam
lambung sangat mempengaruhi
kestabilan bekuan darah yang terbentuk
- bekuan darah stabil bila pH asam
lambung dipertahankan diatas 6
(dalam suasana basa).
KOMPLIKASI
1. PENDARAHAN PERSISTEN
(Re-bleeding)
3.SYOK HIPOVOLEMIK
4.ASPIRASI PNEUMON IA
5.GGA
6.SINDROMA HEPATORENAL
7.KOMA HEPATIKUM
8.ANEMIA BERAT
2. PENDARAHAN BERULANG
INDIKATOR Re-bleeding
PSCBA
1.Rockall Numerical Risk Scoring
System
2.Blatchford Score
3.High-risk Endoscopic finding
4.Co-morbidity
2. Shock :
< 100/min.
< 60
60 79
> 80
No major co-morbidity
Cardiac failure, IHD or any
co-morbidity
0
1
2
0
2
3
Malignancy of UGIT
0
2
Rockall TA, Logan RF, Devlin HB, et al. Risk assessment after acute upper
Full Rockall Score = ./11
gastrointestinal haemorrhage.
INTERPRETATION
: > 8 = Worse
prognosis
Gut.
1996 Mar; 38(3):316-21.
1996 BMJ
Publishing Group Limited.
Glasgow-Blatchford
Bleeding Score (GBS)
Stratifies GI bleeding patients who are "low-
SCORING VALUE
In the validation group, scores of 6 or more
present:
Hemoglobinlevel >12.9 g/dL (men) or >11.9
g/dL (women)
Systolic blood pressure>109mm Hg
Pulse<100/minute
Blood urea nitrogen level <18.2mg/dL
Nomelenaorsyncope
Score points
Is patient female?
Yes
Heart Rate 100
Yes+1
Does the patient have melena?
Yes+1
Did the patient have syncope?
Yes+2
Does the patient have hepatic disease?
Yes+2
Does the patient have heart failure?
Yes+2
Score
points
Hemoglobin Score
Hemoglobin (g/L) for men
12.0 <13.0
1
10.0 <12.0
3
<10.0
6
Hemoglobin (g/L) for women
10.0 <12.0
1
<10.0
6
80 <100
100 <250 4
25
9099
2
<90
3
Pulse 100 (per min)
1
Presentation with melaena
Presentation with syncope
Hepatic disease
2
Cardiac failure
2
1
2
PENATALAKSANAAN PSCBA
DIAGNOSTIK :
Pemeriksaan Penunjang
TERAPEUTIK :
Farmakologis : EDUKASIONAL :
Medikamentosa
MEDIKAMENTOSA
STERILISASI
1. LAKTULOSA
2. NEOMISIN
3. PROBIOTIK
PENDARAHAN VARISEAL :
1. INJEKSI VIT. K
2. SOMATOSTATIN
3. OCTREOTIDE
4. BETABLOKER
5. ISDN/ISMN
GIT :6. ANTIEMESIS
7. HEMOSTATIK LAINNYA
PENDARAHAN NON-VARISEAL
1. H2RA
PPIs
3. SITOPROTEKTOR
2.
Medikamentosa
- Reduksi produksi HCl dan Pepsin
- Menghambat kerja pompa proton
(H+/K+ ATPase pump system)
S block H+ secretion
Proton Pump Inhibitors
PPI
PPIs
PPIS
1.ESOMEPRAZOL
2.Omeprazol
3.Lansoprazol
4.Pantoprazol
OMEPRAZOL
Three days of IV PPI therapy
reduced rebleeding for up to 30
days but did not affect mortality.
J. Stephen Bohan, MD, MS, FACP, FACEP
Published in Journal Watch Emergency Medicine May 1, 2009
Gut doi:10.1136/gut.2010.230292
Guidelines
Asia-Pacific Working Group consensus on
non-variceal upper gastrointestinal bleeding
Published Online First 6 April 2011
1. A pre-endoscopy proton pump inhibitor (PPI) is recommended as
a stop-gap treatment when endoscopy within 24h is not available.
2. An adherent clot on a peptic ulcer should be treated with
endoscopy combined with a PPI if the clot cannot be removed.
Routine repeated endoscopy is not recommended.
3. High-dose intravenous and oral PPIs are recommended but lowdose intravenous PPIs should be avoided.
4. COX-2 selective non-steroidal anti-inflammatory drugs combined
with a PPI are recommended for patients with very high risk of
UGIB.
5. Aspirin should be resumed soon after stabilisation and
clopidogrel alone is no safer than aspirin plus a PPI.
6. When dual antiplatelet agents are used, prophylactic use of a PPI
reduces the risk of adverse gastrointestinal events
Jumlah
Pasien(%)
PPI
iv di
27
23
10
Gastritis
30
RS
Terimakasih..